戻る戻るCANBRIDGE PHARMACEUTICALS INCのTotal liabilities & shareholders' equities (負債および株主資本の合計)
年間データ
0.00
300.00 M
600.00 M
900.00 M
1.20 B
2023
435.30 M
−352.92 M
−44.77%
2022
788.21 M
−303.58 M
−27.81%
2021
1.09 B
+396.58 M
+57.04%
2020
695.21 M
+596.16 M
+601.87%
半期データ
0.00
200.00 M
400.00 M
600.00 M
800.00 M
H1 '24
267.49 M
−167.80 M
−38.55%
H2 '23
435.30 M
−178.60 M
−29.09%
H1 '23
613.90 M
−174.31 M
−22.12%
H2 '22
788.21 M
−199.29 M
−20.18%